Some specific drops:Breast cancer - 127,874Colorectal - 46,705Lung - 375,256Prostate - 476,210Non-Hodgkin lymphoma - 48,836Lead author Dr Joanna MacEwan, from PRECISIONheor, says : \"These findings can help contribute to a better understanding of whether increased spending on cancer drugs are worth the investment. While we do not answer this question directly, our results demonstrate that the result of successful investment--i.e., new cancer therapy approvals--generates significant benefits to patients. \"Though mortality rates were down across many cancers, estimated deaths were up by 825 in people with thyroid cancer, and 7,768 for those with bladder cancer. But there were not many drug approvals during this period: five for thyroid cancer and three for bladder cancer. Coronavirus overturned the belief that vitamin D and vitamin C could prevent everything.